15th Mar, 2017 - 10h (CET) - Impact of Good Pharmacovigilance Practices (GVP) Regulation on Non-Interventional studies

Webinar Topic 

Impact of Good Pharmacovigilance Practices (GVP) Regulation on Non-Interventional studies.


Webinar Date & Time

15th March 2017 from 10:00 to 11:30 (CET)


Webinar Overview

Non-Intervention studies face many unique challenges from regulatory differences across different territories to different standards of care across healthcare providers to increasing large numbers of centres and participants.

These challenges put a sharp focus on the regulations and processes involved to conduct these studies in a compliant manner.

This webinar will outline changes in the European Pharmacovigilance Regulations and may help to deepen awareness of the main topics within the new GVP regarding Non-Intervention studies. Specific focus on Module VIII-Addendum I –Requirements and recommendations for the submission of information on non-interventional post-authorisation safety studies




Dana Vankova, Site & Patient Strategies Director, Clinical Planning and Analytics (CP&A)

Therapeutic Science and Strategy Unit, QuintilesIMS

Remi Gauchoux Head of Late Phase– Lyon, France Late Phase Department, ZEINCRO


Attendance Fee

€ 90,- for EUCROF non-members

€ 60,- for EUCROF members only.


Deadline for registration

14th March 2017


How to register?

1) Click on the green "REGISTER" button on Eventbrite

2) Check your order and click on the green "CHECKOUT" button

3) Fill in all necessaary informations and validate your order



You will receive 2 confirmations email :

A) One from Eventbrite with you invoice

B) One from "GoToWebinar", our new Webinar platform, with all necessary informaiton to connect the D-Day!



Should you have any questions about registration, invoices or connexion, do not hesitate to contact us by email This email address is being protected from spambots. You need JavaScript enabled to view it.